Acceptable Use Policy
This Acceptable Use Policy ("AUP") governs how you may use the MelMat™ platform. It forms part of your agreement with Via Logixs LLC d/b/a MelMat™ and is incorporated into the Terms of Service by reference.
Effective Date June 5, 2026
Version 1.0
Incorporated Into Terms of Service v1.3, Section 7
Section 01
Purpose & Scope

This AUP applies to all users of the MelMat™ platform ("Platform"), including individuals, organizations, and their authorized End Users. It defines the boundaries of acceptable use to protect MelMat's platform integrity, protect third parties, ensure regulatory compliance, and maintain the trust of all users.

This AUP applies to all interactions with the Platform, including research queries submitted, M² Chat and Dig Deeper conversations, data uploaded, outputs generated, and any other use of Platform features. Violations of this AUP may result in suspension or termination of your account as described in Section 8.

Age requirement. The Platform is restricted to users who are at least eighteen (18) years of age, as set forth in the Terms of Service, Section 2.4. The Platform may not be accessed or used by anyone under 18.

Section 02
Permitted Uses

The Platform is licensed for the following purposes:

  • AI-assisted research synthesis for internal business decision-making
  • Document and content summarization for professional use
  • Conversational follow-up via M² Chat and Dig Deeper to clarify, expand, or contextualize research findings
  • Competitive intelligence research and market analysis
  • Regulatory monitoring and compliance research
  • Strategic research to support client advisory work, subject to all professional services requirements in Section 4
  • Any other internal business research purpose consistent with these terms

All permitted uses are subject to the restrictions set forth in this AUP and the full Terms of Service.

Section 03
Prohibited Uses
⚠ Prohibited — The following uses are strictly forbidden Violations may result in immediate account suspension and termination without refund.
Professional & Legal Violations
  • Submit privileged attorney-client communications or confidential client data without first confirming appropriate consent or authority
  • Use AI Outputs as the sole basis for any regulated professional advice — including investment advice, legal advice, tax advice, or insurance recommendations — without independent professional review
  • Represent AI Outputs to clients or third parties as independently verified, human-reviewed, expert-researched, or authoritative without completing such review
  • Upload client files containing Material Non-Public Information (MNPI) that could create securities law liability
Platform Integrity Violations
  • Attempt to prompt-inject, jailbreak, or manipulate the AI system to circumvent safety protocols or produce harmful outputs
  • Harvest, scrape, or systematically extract Platform content for competitive or commercial redistribution
  • Circumvent the Platform's user review or approval workflows
  • Use the Platform to benchmark, train, fine-tune, or improve a competing AI product
  • Reverse engineer, decompile, or attempt to reconstruct the AI models underlying the Platform
  • Reproduce, distribute, or resell access to the Platform without Company's prior written consent
M² Chat & Dig Deeper — Conversational Misuse
  • Use M² Chat or Dig Deeper to harass, threaten, defame, or harm any individual or group
  • Attempt to extract system prompts, training data, internal model instructions, or any non-public information about how the Platform operates
  • Generate sexual, violent, hateful, harassing, or otherwise harmful content through chat
  • Use chat to generate content targeting, sexualizing, grooming, or otherwise involving minors
  • Submit confidential client communications to chat without confirming applicable consent or authority (the same standard that applies to research queries)
  • Attempt to circumvent the per-tier message limits, query caps, or upgrade prompts
  • Use chat to generate or facilitate the creation of malware, exploits, fraud schemes, or other content prohibited by applicable law
Legal & Regulatory Violations
  • Use the Platform for any purpose that violates applicable federal, state, or local law
  • Generate content that infringes third-party intellectual property rights
  • Submit data types prohibited under Section 6 of this AUP without explicit written authorization
  • Use the Platform in a manner that violates Model Rules of Professional Conduct (for attorneys), FINRA/SEC regulations (for RIAs), or applicable ethical rules for your profession
  • Make any representation to clients that AI research satisfies the professional standard for independent due diligence without additional verification
Section 04
Professional Services Users

This section applies to licensed attorneys, CPAs, Registered Investment Advisers, Investment Adviser Representatives, insurance professionals, licensed consultants, and any entity that uses Platform outputs in delivering services to third-party clients.

⚠ Professional Duty Reminder Your professional duties to clients — including duties of competence, diligence, loyalty, independent judgment, and confidentiality — are non-delegable. Use of MelMat AI Output does not substitute for, and does not satisfy, any obligation to conduct independent research, due diligence, or verification required by applicable professional standards or licensing rules.

Professional Services Users additionally agree to:

  • Apply independent professional judgment to evaluate, verify, and confirm the accuracy and appropriateness of AI Output before any client-facing use
  • Not present AI Output to clients as independently verified or authoritative without first completing such review
  • Maintain their own records of AI Output used in client work, including the date, version, query, and disposition of each Output
  • Not represent to clients that AI research satisfies the professional standard for independent due diligence without additional verification
Section 05
AI Output Standards

When using AI Outputs generated by MelMat, all Users agree to the following standards:

  • Accuracy verification: AI Outputs must be independently verified before being presented as factual or authoritative in any professional, client-facing, or public context
  • Attribution: If AI-assisted research is used in deliverables, Users should consider appropriate disclosure practices consistent with applicable professional standards
  • No misrepresentation: Users shall not represent MelMat AI Outputs as more accurate, comprehensive, or reliable than the Platform's actual documented capabilities
  • Confidence scores: Confidence scores displayed in the Platform are probabilistic estimates only and are not guarantees of accuracy
  • Version awareness: Outputs generated under different model versions may differ materially. Users should not rely on Output consistency across sessions
Section 06
Data Submission Standards

The following data types may not be submitted to the Platform without explicit written authorization from MelMat:

  • Protected Health Information (PHI) as defined under HIPAA without an executed Business Associate Agreement
  • Payment card data subject to PCI-DSS
  • Social Security Numbers, government-issued identification numbers, or financial account credentials
  • Biometric data as defined under CCPA/CPRA or applicable state law
  • Children's data subject to COPPA or any data relating to individuals under age 18
  • Privileged attorney-client communications without appropriate client consent and authority
  • Material Non-Public Information (MNPI) subject to securities law restrictions

Submission of prohibited data may constitute a breach of this AUP and applicable law, and may result in immediate account suspension.

Section 07
Account Security
  • You are responsible for maintaining the security of your account and session tokens
  • Do not share account credentials, magic links, or session tokens with unauthorized individuals
  • Magic links expire after 15 minutes and can only be used once — do not forward them
  • If you believe your account has been compromised, contact [email protected] immediately
  • You are responsible for all activity that occurs under your account credentials
Section 08
Enforcement

MelMat reserves the right to investigate any suspected violation of this AUP. Upon determining that a violation has occurred, MelMat may take any of the following actions:

WarningWritten notice of violation with required corrective action
Temporary SuspensionAccount access suspended pending investigation or remediation
Immediate TerminationAccount terminated without refund for serious or repeated violations
Legal ActionReferral to law enforcement or civil legal action where warranted
DisclosureDisclosure to relevant authorities or regulators where required by law

MelMat's enforcement decisions are final. Termination for AUP violations does not entitle User to any refund of subscription fees paid.

Section 09
Reporting Violations

If you become aware of any use of the MelMat platform that violates this AUP, please report it to [email protected] with the subject line "AUP VIOLATION REPORT." We take all reports seriously and will investigate promptly.

Section 10
Relationship to Terms of Service

This AUP is incorporated by reference into MelMat's Terms of Service (Section 7). In the event of any conflict between this AUP and the Terms of Service, the Terms of Service shall govern. Capitalized terms used in this AUP have the meanings given to them in the Terms of Service.

By accepting MelMat's Terms of Service through the First-Login Acceptance Screen, you also agree to this Acceptable Use Policy. This AUP may be updated from time to time consistent with the update procedures described in Section 2.3 of the Terms of Service.

Section 11
Clinical Research Focus — Acceptable Use Standards for Licensed Practitioners

This Section 11 establishes acceptable-use standards for the Clinical Research Focus and any other use of the Platform in connection with clinical, therapeutic, counseling, medical, psychological, or behavioral health work. These standards apply in addition to all other provisions of this AUP. Where Section 11 imposes stricter standards, the stricter standards control. Compliance with Section 21 of the Terms of Service is also required.

11.1 — Permitted Clinical Uses

Subject to all requirements of Section 21 of the Terms of Service, licensed practitioners may use the Clinical Research Focus for:

  • De-identified literature synthesis on clinical frameworks, theoretical models, and research findings
  • Continuing education research, including review of named theorists, frameworks, and points of clinical consensus and disagreement
  • Preparation for case consultation, supervision sessions, or peer-review discussions where no patient-identifying information is submitted
  • Identification of research gaps, methodological limitations, and contested areas of the clinical literature
  • Structured prompts for the practitioner's own clinical reasoning and case formulation, where no patient-identifying information is submitted
  • Preparation of teaching materials, didactic content, and supervision frameworks, where no patient-identifying information is submitted
11.2 — Prohibited Clinical Submissions

You may not submit to the Platform, in any focus mode (including Clinical Research, General, or any other focus), any of the following:

  • Protected Health Information (PHI) as defined under HIPAA, the HITECH Act, or any state or international equivalent
  • Patient names, initials, dates of birth, ages over 89, addresses, telephone numbers, email addresses, medical record numbers, account numbers, health plan beneficiary numbers, certificate or license numbers, vehicle identifiers, device identifiers, IP addresses, biometric identifiers, full-face photographs, or any other direct identifiers enumerated in 45 C.F.R. § 164.514(b)(2)
  • Any combination of indirect identifiers (such as rare diagnoses combined with geographic identifiers and dates of service) that could reasonably permit re-identification of a specific individual
  • Verbatim quotes from session transcripts, clinical notes, intake forms, treatment plans, or any other clinical documentation pertaining to an identifiable individual
  • Detailed case material — including specific symptom timelines, treatment histories, family-system details, or psychosocial stressors — sufficient to identify a specific client, patient, supervisee, or third party
  • Test data, assessment results, or scored instruments containing identifying information
  • Audio recordings, video recordings, or transcripts of clinical sessions in any form
  • Health-information of any minor, decedent, or legally incapacitated person, regardless of consent status
  • Information obtained from any patient portal, EHR, clinical information system, or healthcare data source where transfer of such data violates the source system's terms or applicable law
11.3 — Prohibited Clinical Use Cases

You may not use any Platform output, regardless of focus mode, for any of the following purposes:

  • Making patient-care decisions for an identifiable individual without independent verification through peer-reviewed literature, current clinical guidelines, and your own clinical judgment
  • Generating documentation that will be incorporated into a patient's medical record, treatment plan, progress notes, intake assessment, discharge summary, or any other clinical record
  • Generating diagnostic determinations, differential diagnoses, or rule-out decisions for an identifiable individual
  • Generating prescriptions, medication recommendations, dosing guidance, or pharmacological decision support
  • Generating risk assessments for suicide, homicide, self-harm, child abuse, elder abuse, intimate partner violence, or any other matter requiring real-time clinical judgment
  • Generating mandatory reporting determinations or content of mandatory reports
  • Generating content for use in forensic evaluations, custody evaluations, fitness-for-duty evaluations, disability evaluations, or any other legally consequential clinical assessment
  • Generating content for use as evidence, exhibit, or substantive submission in any judicial, administrative, licensing, or regulatory proceeding
  • Generating clinical guidance for cases involving imminent harm, psychiatric emergency, or any matter requiring real-time professional response
  • Substituting Platform output for clinical supervision, consultation, peer review, or any other professional oversight required by your licensing body or scope of practice
  • Representing Platform output to clients, patients, supervisees, students, or third parties as clinical advice, diagnosis, treatment recommendation, or professional opinion
  • Using the Platform on behalf of, or for the direct benefit of, an identifiable client or patient in lieu of providing licensed clinical services
  • Bypassing, evading, or substituting for any consent process, informed-consent requirement, treatment-agreement provision, or scope-of-practice limitation applicable to your licensed practice
11.4 — Crisis Content Prohibition

The Platform is not equipped to handle crisis content and may not be used in any situation involving imminent risk of suicide, self-harm, harm to others, active abuse, or psychiatric emergency. Where such content arises in the course of your clinical practice, you must immediately route the affected individual to appropriate emergency services, crisis hotlines, or licensed clinicians with crisis training. Submission of crisis content to the Platform — including but not limited to detailed suicidal ideation, active homicidal ideation, active self-harm planning, or active abuse disclosures — is a violation of this AUP and may result in immediate account suspension. Where the Platform's safeguards detect content that appears to involve imminent harm, Company may refuse to process the query, may surface crisis resources, and may flag the account for review consistent with Section 8.

11.5 — Mandatory Reporting

You retain all mandatory reporting obligations independent of any Platform output. The Platform is not a mandatory reporting service. Platform output does not satisfy, modify, replace, or excuse any obligation to report suspected child abuse, elder abuse, dependent-adult abuse, threats of harm to identifiable third parties, or any other report required by your licensing body, statute, or rule. You may not rely on Platform output to determine whether a mandatory report is required, what the content of a mandatory report should be, or what timeline applies to a mandatory report.

11.6 — Supervisory Use Standards

When using the Platform in the context of clinical supervision: (a) you must inform supervisees that the Platform is a research aid, not a substitute for supervised clinical judgment; (b) you may not use Platform output as a substantive basis for evaluating supervisee competency, clinical readiness, or fitness for licensure; (c) you may not require supervisees to submit case material to the Platform; (d) you remain solely responsible for all supervisory decisions; and (e) you may not delegate to the Platform any portion of the supervisory relationship that requires the supervisor's independent clinical judgment.

11.7 — Coaching and Non-Licensed Use

Coaches, peer-support workers, and other non-licensed practitioners may access the Clinical Research Focus for educational and self-directed learning purposes only. Non-licensed users may not: (a) represent Platform output as clinical advice, diagnostic support, or treatment recommendation to clients, customers, or third parties; (b) use Platform output to perform any function that requires a clinical license in the user's jurisdiction; (c) use Platform output to advise clients on matters that exceed the scope of coaching practice (including but not limited to diagnosable mental-health conditions, medication questions, or matters requiring clinical risk assessment); or (d) use the Platform in any way that violates the scope-of-practice rules of the user's jurisdiction. Where coaching engagement reveals clinical-level concerns, the appropriate response is referral to a licensed clinician, not Platform consultation.

11.8 — De-Identification Burden

The user bears sole responsibility for ensuring that all submitted content is de-identified to the standard required under 45 C.F.R. § 164.514(b)(2) safe-harbor or, where applicable, expert determination under 45 C.F.R. § 164.514(b)(1). Company does not screen, de-identify, anonymize, or otherwise modify user submissions. Submission of identifiable content is a material violation of this AUP and the Terms of Service regardless of Company's processing of such submission.

11.9 — Enforcement of Section 11

Violations of this Section 11 may result in immediate account suspension or termination consistent with Section 8 of this AUP. Where Company has a reasonable basis to believe that a user has submitted PHI or other prohibited clinical content, Company may: (a) suspend the account pending investigation; (b) require user attestation regarding the nature of the submitted content; (c) require user remediation, including engagement of independent counsel regarding any privacy breach; (d) report apparent violations of healthcare privacy law to appropriate regulators where required by law; and (e) terminate the account with no refund. Section 11 violations are non-curable for purposes of the cure provisions in Section 8.

This Acceptable Use Policy is effective as of June 5, 2026 and applies to all users of the MelMat™ platform.

Vanja Todorovic
Owner, Via Logixs LLC d/b/a MelMat™
Tampa, Florida
June 5, 2026